ArticleCureus2025

Evaluation of Cardiotoxicity in Lymphoproliferative Patients Treated With Anthracycline and Bruton's Tyrosine Kinase Inhibitor-Based Regimens.

Andrew BonsuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.